MHRA investigates medicines that left supply chain as FMD alert issued

The Medicines and Healthcare products Regulatory Agency (MHRA) is investigating circumstances under which multiple medicines left the supply chain before entering it again.

Screen%20Shot%202020-09-09%20at%2013.36.25.jpg
The products are thought to have left the legitimate supply chain before being reintroduced

Latest from News

More from Regulation